These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 33046974)

  • 1. Prognostic alternative splicing signature reveals the landscape of immune infiltration in Pancreatic Cancer.
    Wang L; Bi J; Li X; Wei M; He M; Zhao L
    J Cancer; 2020; 11(22):6530-6544. PubMed ID: 33046974
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of Prognostic Alternative Splicing Reveals the Landscape of Immune Microenvironment in Thyroid Cancer.
    Wu J; Sun Y; Li J; Ai M; You L; Shi J; Yu F
    Front Oncol; 2021; 11():763886. PubMed ID: 34733794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients.
    Wang L; Wei Q; Zhang M; Chen L; Li Z; Zhou C; He M; Wei M; Zhao L
    Int Immunopharmacol; 2020 Oct; 87():106795. PubMed ID: 32707495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma.
    Chen B; Deng T; Deng L; Yu H; He B; Chen K; Zheng C; Wang D; Wang Y; Chen G
    BMC Cancer; 2021 Nov; 21(1):1211. PubMed ID: 34772375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
    Lai J; Yang H; Xu T
    BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
    Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
    Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer.
    Chen J; Liao Y; Li R; Luo M; Wu G; Tan R; Xiao Z
    Technol Cancer Res Treat; 2022; 21():15330338221090093. PubMed ID: 35509211
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification and Validation of a Prognostic Immune-Related Alternative Splicing Events Signature for Glioma.
    Wang M; Zhou Z; Zheng J; Xiao W; Zhu J; Zhang C; Jiang X
    Front Oncol; 2021; 11():650153. PubMed ID: 34055619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma.
    Ye F; Wu P; Zhu Y; Huang G; Tao Y; Liao Z; Guan Y
    Front Genet; 2022; 13():989081. PubMed ID: 36338975
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 12. The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Chen F; Gong X; Xia M; Yu F; Wu J; Yu C; Li J
    Front Oncol; 2022; 12():857994. PubMed ID: 35619896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
    Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
    J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a prognostic model with exosome biogenesis- and release-related genes and identification of RAB27B in immune infiltration of pancreatic cancer.
    Li TY; Qin C; Zhao BB; Li ZR; Wang YY; Zhao YT; Wang WB
    Transl Cancer Res; 2024 Sep; 13(9):4846-4865. PubMed ID: 39430819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma.
    Xu Q; Xu H; Deng R; Li N; Mu R; Qi Z; Shen Y; Wang Z; Wen J; Zhao J; Weng D; Huang W
    Cancer Cell Int; 2021 Apr; 21(1):190. PubMed ID: 33794886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of a new immune-related prognostic signature for esophageal cancer and its correlation with infiltrating immune cells and target genes.
    Peng Z; Liu XY; Cheng Z; Kai W; Song Z
    Ann Transl Med; 2021 Oct; 9(20):1576. PubMed ID: 34790782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
    Zhang D; Duan Y; Wang Z; Lin J
    Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.
    Duan Y; Zhang D
    J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma.
    Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y
    Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.
    Zhang B; Wang Q; Fu C; Jiang C; Ma S
    Ann Transl Med; 2019 Dec; 7(23):730. PubMed ID: 32042746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.